Similar survival benefits of a good response and stable disease to platinum-based chemotherapy in non-small cell lung cancer

By            

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 1135-1140

Spandidos Publications

Access to resources Recommend Favorite

Predicting toxicity in advanced lung cancer patients treated with platinum-based chemotherapy

By Ioannidis Georgios   Souglakos John   Georgoulias Vassilis  

Lung Cancer Management, Vol. 2, Iss. 4, 2013-08 ,pp. : 281-293

Future Medicine

Access to resources Recommend Favorite

Resistance to platinum-based chemotherapy in lung cancer cell lines

By Chen Jianli   Emara Nashwa   Solomides Charalambos   Parekh Hemant   Simpkins Henry  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1103-1111

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic implications of survivin and lung resistance protein in advanced non-small cell lung cancer treated with platinum-based chemotherapy

By                      

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 723-730

Spandidos Publications

Access to resources Recommend Favorite

High response of second-line chemotherapy with pemetrexed or gemcitabine combined with carboplatin in patients with non-small-cell lung cancer experiencing progression following 6 months after concluding platinum-based chemotherapy

By Arrieta Oscar  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 300-306

Humana Press, Inc

Access to resources Recommend Favorite